Gastroretentive raft liquid delivery system as a new approach to release extension for carrier-mediated drug

References

• Abou Youssef NA, Kassem AA, El-Massik MA, Boraie NA. (2015). Development of gastroretentive metronidazole floating raft system for targeting Helicobacter pylori. Int J Pharm 486:297–305.
   PubMed Web of Science ®Google Scholar
• Abouelatta SM, Aboelwafa AA, Khalil RM, ElGazayerly ON. (2015). Floating lipid beads for the improvement of bioavailability of poorly soluble basic drugs: in-vitro optimization and in-vivo performance in humans. Eur J Pharm Biopharm 89:82–92.
   PubMed Web of Science ®Google Scholar
• Abouelatta SM, Aboelwafa AA, Khalil RM, El-Gazayerly ON. (2016). Utilization of ionotropic gelation technique for bioavailability enhancement of cinnarizine: in-vitro optimization and in-vivo performance in human. Drug Deliv 23:2736–46.
   PubMed Web of Science ®Google Scholar
• Ahuja M, Singh S, Kumar A. (2013). Evaluation of carboxymethyl gellan gum as a mucoadhesive polymer. Int J Biol Macromol 53:114–21.
   PubMed Web of Science ®Google Scholar
• Basha M, Abd El-Alim SH, Shamma RN, Awad GE. (2013). Design and optimization of surfactant-based nanovesicles for ocular delivery of Clotrimazole. J Liposome Res 23:203–10.
   PubMed Web of Science ®Google Scholar
• Beal B, Moeller-Bertram T, Schilling JM, Wallace MS. (2012). Gabapentin for once-daily treatment of post-herpetic neuralgia: a review. Clin Interv Aging 7:249.
   PubMed Web of Science ®Google Scholar
• Chen C, E Cowles V, Sweeney M. (2013a). The intestinal absorption mechanism of gabapentin makes it appropriate for gastroretentive delivery. Curr Clin Pharmcol 8:67–72.
   PubMedGoogle Scholar
• Chen C, Han CHS, Sweeney M, Cowles VE. (2013b). Pharmacokinetics, efficacy, and tolerability of a once‐daily gastroretentive dosage form of gabapentin for the treatment of postherpetic neuralgia. J Pharm Sci 102:1155–64.
   PubMed Web of Science ®Google Scholar
• El-Nabarawi MA, Bendas ER, El Rehem RTA, Abary MY. (2013). Transdermal drug delivery of paroxetine through lipid-vesicular formulation to augment its bioavailability. Int J Pharm 443:307–17.
   PubMed Web of Science ®Google Scholar
• Fernandes A, Ferreira N, Fangueiro J, et al. (2017). Ibuprofen nanocrystals developed by 22 factorial design experiment: a new approach for poorly water-soluble drugs. Saudi Pharm J 25:1117–24.
   PubMed Web of Science ®Google Scholar
• Gordi T, Hou E, Kasichayanula S, Berner B. (2008). Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive-extended-release and immediate-release tablets: a randomized, open-label, multiple-dose, three-way crossover, exploratory study in healthy subjects. Clin Therap 30:909–16.
   PubMed Web of Science ®Google Scholar
• Gupta A, Ciavarella AB, Sayeed VA, et al. (2008). Development and application of a validated HPLC method for the analysis of dissolution samples of gabapentin drug products. J Pharm Biomed Anal 46:181–6.
   PubMed Web of Science ®Google Scholar
• Itoh K, Hirayama T, Takahashi A, et al. (2007). In situ gelling pectin formulations for oral drug delivery at high gastric pH. Int J Pharm 335:90–6.
   PubMed Web of Science ®Google Scholar
• Itoh K, Yahaba M, Takahashi A, et al. (2008). In situ gelling xyloglucan/pectin formulations for oral sustained drug delivery. Int J Pharm 356:95–101.
   PubMed Web of Science ®Google Scholar
• Kelly J, Wright D. (2009). Administering medication to adult patients with dysphagia. Nursing Stand J 23:62–8.
   PubMedGoogle Scholar
• Kerdsakundee N, Mahattanadul S, Wiwattanapatapee R. (2015). Development and evaluation of gastroretentive raft forming systems incorporating curcumin-Eudragit® EPO solid dispersions for gastric ulcer treatment. Eur J Pharm Biopharm 94:513–20.
   PubMed Web of Science ®Google Scholar
• Kim J-Y, Kim S-h, Rhee Y-S, et al. (2013). Preparation of hydroxypropylmethyl cellulose-based porous matrix for gastroretentive delivery of gabapentin using the freeze-drying method. Cellulose 20:3143–54.
   Web of Science ®Google Scholar
• Kong V, Irwin M. (2007). Gabapentin: a multimodal perioperative drug? Br J Anaesth 99:775–86.
   PubMed Web of Science ®Google Scholar
• Lewis GA, Mathieu D, Phan-Tan-Luu R. 1998. Pharmaceutical experimental design. New York, USA: CRC Press.
   Google Scholar
• Liu Y, Zhang J, Gao Y, Zhu J. (2011). Preparation and evaluation of glyceryl monooleate-coated hollow-bioadhesive microspheres for gastroretentive drug delivery. Int J Pharm 413:103–9.
   PubMed Web of Science ®Google Scholar
• McLean MJ. (1994). Clinical pharmacokinetics of gabapentin. Neurology 44:S17–S22. discussion S31-12.
   PubMed Web of Science ®Google Scholar
• Moffat AC, Osselton MD, Widdop B. (2004). Clarke’s analysis for drugs and poisons. 4th ed. London: Pharmaceutical Press.
   Google Scholar
• Morsi NM, Abdelbary GA, Ahmed MA. (2014). Silver sulfadiazine based cubosome hydrogels for topical treatment of burns: development and in vitro/in vivo characterization. Eur J Pharm Biopharm 86:178–89.
   PubMed Web of Science ®Google Scholar
• Nagarwal RC, Srinatha A, Pandit JK. (2009). In situ forming formulation: development, evaluation, and optimization using 3(3) factorial design. AAPS PharmSciTech 10:977–84.
   PubMed Web of Science ®Google Scholar
• Park JH, Jhee OH, Park SH, et al. (2007). Validated LC‐MS/MS method for quantification of gabapentin in human plasma: application to pharmacokinetic and bioequivalence studies in Korean volunteers. Biomed Chromatogr 21:829–35.
   PubMed Web of Science ®Google Scholar
• Prajapati VD, Jani GK, Khutliwala TA, Zala BS. (2013). Raft forming system-an upcoming approach of gastroretentive drug delivery system. J Control Release 168:151–65.
   PubMed Web of Science ®Google Scholar
• Rajinikanth PS, Balasubramaniam J, Mishra B. (2007). Development and evaluation of a novel floating in situ gelling system of amoxicillin for eradication of Helicobacter pylori. Int J Pharm 335:114–22.
   PubMed Web of Science ®Google Scholar
• Rajinikanth PS, Mishra B. (2008). Floating in situ gelling system for stomach site-specific delivery of clarithromycin to eradicate H. pylori. J Control Release 125:33–41.
   PubMed Web of Science ®Google Scholar
• Rawlins EA. 1977. Bentley’s textbook of pharmaceutics. 8th ed. London: Bailliere Tindall.
   Google Scholar
• Shimoyama T, Itoh K, Kobayashi M, et al. (2012). Oral liquid in situ gelling methylcellulose/alginate formulations for sustained drug delivery to dysphagic patients. Drug Dev Ind Pharm 38:952–60.
   PubMed Web of Science ®Google Scholar
• Tayel SA, El-Nabarawi MA, Tadros MI, Abd-Elsalam WH. (2013). Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits. Int J Pharm 443:293–305.
   PubMed Web of Science ®Google Scholar